EVOLVE-@ was a randomized , double-blind , phase @ study conducted among @ adults with Barcelona Clinic Liver Cancer stage B or C hepatocellular carcinoma and Child-Pugh A liver function whose disease progressed during or after sorafenib or who were intolerant of sorafenib .